CorMedix Inc (CRMD)

Currency in USD
10.330
-0.480(-4.44%)
Closed·
After Hours
10.350+0.020(+0.19%)
·

CRMD Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
0.28 / 0.16
Revenue / Forecast
39.70M / 33.06M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
09/2025--/0.237--/41.11M----Free Sign Up
06/20250.28/0.1639.7M/33.06M+75%+20.08%Free Sign Up
03/20250.3/0.1639.08M/32.35M+87.5%+20.8%Free Sign Up
12/20240.22/0.1731.2M/31M+29.41%+0.65%Free Sign Up
09/2024-0.05/-0.1111.5M/10.35M+54.55%+11.11%Free Sign Up
06/2024-0.25/-0.25810K/1.66M0%-51.2%Free Sign Up
03/2024-0.25/-0.26--/3M+3.85%-100%Free Sign Up
12/2023-0.26/-0.19--/-333,330,000,000-36.84%+100%Free Sign Up
09/2023-0.17/-0.21--/--+19.05%--Free Sign Up
06/2023-0.25/-0.24--/---4.17%--Free Sign Up

All numbers in USD

CorMedix Inc Earnings Call Summary for Q1/2025

  • Q1 2025 EPS of $0.32, doubling forecast; revenue at $39.1M, surpassing expectations by $6.75M
  • Stock rose 6.3% premarket to $9.599; net income of $20.6M vs. $14.5M loss in Q1 2024
  • Revised H1 2025 net revenue guidance to ~$70M; targeting FDA approval for new indication by late 2027
  • Strong performance attributed to DefendCath momentum and strategic market expansions
  • Analysts maintain Strong Buy consensus; stock targets range from $12 to $19 per share
Last Updated: 06/05/2025, 14:34
Read Full Transcript

FAQ

What Is CorMedix's Earnings Per Share (TTM)?

The CorMedix EPS (TTM) is 0.81.

When Is The Next CorMedix Earnings Date?

CorMedix will release its next earnings report on 05 Nov 2025.

What Is CorMedix’s Revenue Forecasts For Upcoming Quarters?

CorMedix’s revenue forecast is 41.11M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.